Inhibition of DPP4, DPP8, DPP9 and FAP by Val-boroPro has been shown to mediate regression in multiple tumour models, likely, at least in part, via the modulation of immune responses [10,12,21]. The gene discussed is FAP; the disease is neoplasm.